Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
February 12 2023 - 9:05PM
Business Wire
Ad Hoc Announcement Pursuant to Art. 53 LR
Regulatory News:
Alcon Inc. ("Alcon") (SIX/NYSE: ALC), the global leader in eye
care dedicated to helping people see brilliantly, today announced
that it has entered into a settlement agreement with J&J
Surgical Vision, Inc. to resolve their pending legal proceedings
relating to femtosecond laser assisted cataract surgery devices,
including Alcon’s LenSx® device, which Alcon acquired as part of
its purchase of LenSx Lasers, Inc. in 2010. As part of the
resolution of this matter, the parties have exchanged
cross-licenses of certain intellectual property and other mutually
agreed covenants and releases, and Alcon will make a one-time
payment to J&J Surgical Vision, Inc. of USD 199 million for
those rights and to resolve various worldwide intellectual property
disputes relating to this matter.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning over 75 years, we offer the broadest
portfolio of products to enhance sight and improve people’s lives.
Our Surgical and Vision Care products touch the lives of more than
260 million people in over 140 countries each year living with
conditions like cataracts, glaucoma, retinal diseases and
refractive errors. Our more than 24,000 associates are enhancing
the quality of life through innovative products, partnerships with
Eye Care Professionals and programs that advance access to quality
eye care.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230212005023/en/
Investor Relations Dan
Cravens Allen Trang + 41 589 112 110 (Geneva) + 1 817 615 2789
(Fort Worth) investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Oct 2023 to Oct 2024